Aspen Aerogels, Inc. (ASPN) Financial Statements
Aspen Aerogels, Inc. (ASPN) reported trailing twelve-month revenue of $202.1M (down 49.1% year on year) and net income of -$126.2M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $34.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ASPNAspen Aerogels, Inc.Follow ASPN — free
—
Price chart with a free account
- Market cap
- 458.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 23 Feb, in 122 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 102.4 | 122.5 | 117.7 | 111.6 | 104.4 | 139.4 | 100.3 | 121.6 | 180.4 | 238.7 | 452.7 | 271.1 | 202.1 | |
| Gross profit | 17.1 | 24.6 | 23.3 | 18.7 | 12.7 | 26.3 | 14.6 | 9.9 | 5.0 | 56.9 | 182.9 | 46.0 | 5.4 | |
| Research & development | 6.0 | 5.3 | 5.3 | 6.2 | 6.3 | 8.4 | 8.7 | 11.4 | 16.9 | 16.4 | 18.1 | 13.4 | 11.2 | |
| Operating income | -16.0 | -6.2 | -11.2 | -19.1 | -33.9 | -14.2 | -21.6 | -40.6 | -79.2 | -49.2 | 54.5 | -378.2 | -123.4 | |
| Pre-tax income | — | — | — | — | — | — | — | — | — | -45.8 | 15.1 | -387.2 | -125.3 | |
| Income tax | — | — | — | — | — | — | — | — | — | 0.0 | 1.7 | 2.4 | 0.9 | |
| Net income | -66.3 | -6.4 | -12.0 | -19.3 | -34.4 | -14.6 | -21.8 | -37.1 | -82.7 | -45.8 | 13.4 | -389.6 | -126.2 | |
| Diluted EPS ($) | -5.37 | -0.28 | -0.52 | -0.83 | -1.45 | -0.60 | -0.83 | -1.22 | -2.10 | -0.66 | 0.17 | -4.73 | -1.53 | |
| Diluted shares (mn) | 12.3 | 23.0 | — | — | — | — | 26.4 | 30.4 | 39.4 | 69.4 | 80.3 | 82.3 | — |
USD millions · SEC XBRL
Aspen Aerogels, Inc. — questions
- What is Aspen Aerogels, Inc.'s revenue?
- $202.1M over the twelve months to 2026-06-30, down 49.1% year on year, from its 10-Q and 10-K filings.
- What is Aspen Aerogels, Inc.'s net income?
- -$126.2M over the twelve months to 2026-06-30.
- What is Aspen Aerogels, Inc.'s free cash flow?
- $34.4M over the twelve months to 2026-06-30.
- What are Aspen Aerogels, Inc.'s diluted earnings per share?
- $-1.53 over the twelve months to 2026-06-30.
Every figure on this page comes from Aspen Aerogels, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.